For the quarter ended September 2026, Encompass Health (EHC Quick QuoteEHC - Free Report) reported revenue of $1.61 billion, up 8.9% over the same period last year. EPS came in at $1.52, compared to $1.23 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $1.6 billion, representing a surprise of +0.63%. The company delivered an EPS surprise of +10.15%, with the consensus EPS estimate being $1.38.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Encompass Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Net patient revenue per discharge: $22,543.00 versus $22,147.45 estimated by two analysts on average.
• Discharges: 69,605 compared to the 69,869 average estimate based on two analysts.
• Net Operating Revenues- Other: $40.4 million versus the two-analyst average estimate of $50.71 million. The reported number represents a year-over-year change of -19.5%.
• Net Operating Revenues- Inpatient: $1.57 billion compared to the $1.55 billion average estimate based on two analysts. The reported number represents a change of +9.9% year over year.

View all Key Company Metrics for Encompass Health here>>>

Shares of Encompass Health have returned -1.6% over the past month versus the Zacks S&P 500 composite's -0.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.